SEP 8, 2026 · PHASE 3 TRIAL
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
ClinicalTrials.gov
This is an active Phase 3 trial registration with no results posted; the study design and primary endpoints are defined but efficacy and safety data are not yet available.
Reported
Planned enrollment800
Study phasePHASE 3
Primary outcome measure 1Percent Change from Baseline in Body Weight…